Screening for Down Syndrome in Pregnant Women in Anar County Using Serum Markers: Alpha-Fetoprotein, Pregnancy-Associated Plasma Protein A, and hCG
سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 37
فایل این مقاله در 9 صفحه با فرمت PDF قابل دریافت می باشد
- صدور گواهی نمایه سازی
- من نویسنده این مقاله هستم
استخراج به نرم افزارهای پژوهشی:
شناسه ملی سند علمی:
JR_IJMR-13-2_005
تاریخ نمایه سازی: 20 آبان 1405
چکیده مقاله:
Introduction: Down syndrome (DS), caused by trisomy ۲۱, is a common chromosomal abnormality associated with intellectual disability, developmental delays, and characteristic physical features. Prenatal screening enables early risk assessment and informed decision-making. Advanced maternal age is a major risk factor, highlighting the need to consider maternal age alongside biochemical and ultrasound markers. This study investigated the association between maternal age and key prenatal markers—including Pregnancy-Associated Plasma Protein A (PAPP-A), β-human Chorionic Gonadotropin (β-hCG), AlphaFetoprotein (AFP), Inhibin A, unconjugated Estriol (uE۳), and Nuchal Translucency (NT)—and evaluated their contribution to Down syndrome risk stratification across maternal age groups.Methods: A cross-sectional study was conducted on ۱۳۸ pregnant women referred to a diagnostic laboratory in Anar County, Kerman Province. Serum markers were measured in first- and second-trimester screenings, alongside ultrasound assessment of NT. Statistical analyses, including one-way ANOVA, examined associations between maternal age, markers, NT, and estimated Down syndrome risk.Results: Maternal age was significantly associated with estimated Down syndrome risk, highest among women aged ۴۰–۴۵ years and lowest in those aged ۲۰–۲۵ years. AFP and uE۳ demonstrated the strongest predictive associations with risk, whereas PAPP-A, β-hCG, and NT contributed less prominently.Conclusion: Combined prenatal screening using maternal serum markers and NT improves early identification of pregnancies at increased risk for Down syndrome. Integrating maternal age with biochemical screening optimizes risk stratification, especial ly in regional programs. Further multicenter studies are recommended to confirm and expand these findings .
کلیدواژه ها:
نویسندگان
Mohaddeseh Soleymani
Shahid Bahonar University of Kerman Master of Science in Cell and Molecular Biology Specialization: Genetics
Kamran Vosoo
Department of science, Faculty of biology, Payame Noor University, Qeshm, Iran